Status:
RECRUITING
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
Lead Sponsor:
McGill University
Collaborating Sponsors:
Jewish General Hospital
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Lymphoma
Cancer Survivors
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
This randomized control trial seeks to determine whether a tailored and supervised exercise program adopting mobile-health technology will be able to improve fitness and quality of life among lymphoma...
Detailed Description
Lymphoma is the most common cancer diagnosed in young adults. While curing 80% of patients, lymphoma treatment has a significant impact on young adults' health and psycho-social wellbeing by increasin...
Eligibility Criteria
Inclusion
- newly diagnosed lymphoma patients who received an initial diagnosis at the age of age 18-39,
- approved by their hematologist as having no contra-indications to vigorous exercise,
- receiving or has received chemotherapy with curative intent within the past 6 months,
- own a cellular phone that is able to download the Fitbit app and to complete the study questionnaires online in either French or English, and
- has an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom).
Exclusion
- The patient has contra-indications to vigorous exercise,
- the patient doesn't want to wear a fitness tracker due to various concerns (as no Fitbit data could be collected).
Key Trial Info
Start Date :
January 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05257785
Start Date
January 15 2022
End Date
December 1 2024
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jewish General Hospital
Montreal, Quebec, Canada, H3A 2A7